NLS Pharmaceutics AG
NASDAQ:NLSP
NLS Pharmaceutics AG
Cash from Investing Activities
NLS Pharmaceutics AG
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Cash from Investing Activities
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Novartis AG
SIX:NOVN
|
Cash from Investing Activities
-$5.9B
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-104%
|
CAGR 10-Years
-17%
|
|
Roche Holding AG
SIX:ROG
|
Cash from Investing Activities
-CHf10.6B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-23%
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Cash from Investing Activities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is NLS Pharmaceutics AG's Cash from Investing Activities?
Cash from Investing Activities
0
USD
Based on the financial report for Dec 31, 2022, NLS Pharmaceutics AG's Cash from Investing Activities amounts to 0 USD.